Stay updated on CM-24 Combo Study With Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CM-24 Combo Study With Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T01:30:56.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.2.0 to v3.3.1. This is a minor metadata change and does not modify the study details.
    Difference
    0.0%
    Check dated 2025-11-20T22:28:27.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Removed the general government funding operating status notice from the page; the notice previously directed users to opm.gov for updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-13T16:54:00.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The study record content remains the same; only minor layout changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-30T11:19:19.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Adds v3.2.0 and removes a specific disease resource (Ovarian cancer); minor content scope change and update history.
    Difference
    0.4%
    Check dated 2025-10-01T03:52:03.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added v3.1.0 revision; removed Ovarian cancer resource under Genetic and Rare Diseases Information Center; removed older v3.0.2 revision.
    Difference
    0.4%
    Check dated 2025-09-30T02:55:39.000Z thumbnail image

Stay in the know with updates to CM-24 Combo Study With Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.